Literature DB >> 22981234

Generation and characterization of severe combined immunodeficiency rats.

Tomoji Mashimo1, Akiko Takizawa, Junya Kobayashi, Yayoi Kunihiro, Kazuto Yoshimi, Saeko Ishida, Koji Tanabe, Ami Yanagi, Asato Tachibana, Jun Hirose, Jun-ichiro Yomoda, Shiho Morimoto, Takashi Kuramoto, Birger Voigt, Takeshi Watanabe, Hiroshi Hiai, Chise Tateno, Kenshi Komatsu, Tadao Serikawa.   

Abstract

Severe combined immunodeficiency (SCID) mice, the most widely used animal model of DNA-PKcs (Prkdc) deficiency, have contributed enormously to our understanding of immunodeficiency, lymphocyte development, and DNA-repair mechanisms, and they are ideal hosts for allogeneic and xenogeneic tissue transplantation. Here, we use zinc-finger nucleases to generate rats that lack either the Prkdc gene (SCID) or the Prkdc and Il2rg genes (referred to as F344-scid gamma [FSG] rats). SCID rats show several phenotypic differences from SCID mice, including growth retardation, premature senescence, and a more severe immunodeficiency without "leaky" phenotypes. Double-knockout FSG rats show an even more immunocompromised phenotype, such as the abolishment of natural killer cells. Finally, xenotransplantation of human induced pluripotent stem cells, ovarian cancer cells, and hepatocytes shows that SCID and FSG rats can act as hosts for xenogeneic tissue grafts and stem cell transplantation and may be useful for preclinical testing of new drugs.
Copyright © 2012 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981234     DOI: 10.1016/j.celrep.2012.08.009

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  34 in total

Review 1.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

2.  Sprague Dawley Rag2-Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts.

Authors:  Fallon K Noto; Valeriya Adjan-Steffey; Goutham Narla; Tseten Y Jamling; Min Tong; Kameswaran Ravichandran; Wei Zhang; Angela Arey; Christopher B McClain; Eric Ostertag; Sahar Mazhar; Jaya Sangodkar; Analisa DiFeo; Jack Crawford
Journal:  Mol Cancer Ther       Date:  2018-09-11       Impact factor: 6.261

3.  Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency.

Authors:  Kiho Lee; Deug-Nam Kwon; Toshihiko Ezashi; Yun-Jung Choi; Chankyu Park; Aaron C Ericsson; Alana N Brown; Melissa S Samuel; Kwang-Wook Park; Eric M Walters; Dae Young Kim; Jae-Hwan Kim; Craig L Franklin; Clifton N Murphy; R Michael Roberts; Randall S Prather; Jin-Hoi Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

Review 4.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

Review 5.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

Review 6.  Application of genome editing technologies in rats for human disease models.

Authors:  Kazuto Yoshimi; Tomoji Mashimo
Journal:  J Hum Genet       Date:  2017-11-20       Impact factor: 3.172

7.  Near-infrared fluorescence imaging of non-Hodgkin's lymphoma CD20 expression using Cy7-conjugated obinutuzumab.

Authors:  Xinfeng Lin; Hua Zhu; Zheng Luo; Ye Hong; Hong Zhang; Xijuan Liu; Huirong Ding; Huifang Tian; Zhi Yang
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

8.  Oxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain.

Authors:  Csaba Imre Szalay; Katalin Erdélyi; Gábor Kökény; Enikő Lajtár; Mária Godó; Csaba Révész; Tamás Kaucsár; Norbert Kiss; Márta Sárközy; Tamás Csont; Tibor Krenács; Gábor Szénási; Pál Pacher; Péter Hamar
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

9.  Efficient gene targeting by TAL effector nucleases coinjected with exonucleases in zygotes.

Authors:  Tomoji Mashimo; Takehito Kaneko; Tetsushi Sakuma; Junya Kobayashi; Yayoi Kunihiro; Birger Voigt; Takashi Yamamoto; Tadao Serikawa
Journal:  Sci Rep       Date:  2013-02-13       Impact factor: 4.379

10.  Direct induction of chondrogenic cells from human dermal fibroblast culture by defined factors.

Authors:  Hidetatsu Outani; Minoru Okada; Akihiro Yamashita; Kanako Nakagawa; Hideki Yoshikawa; Noriyuki Tsumaki
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.